BLISSGVSNSEBLISS GVS PHARMA LTD· PharmaceuticalsMinimalNeutral
Announced Mon, 20 Jul · 12:54 IST

Addendum adds Mates Visa as PAC to Anupam Rasayan's open offer for Bliss GVS Pharma

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.6%1-day move
₹485.00
prior close
₹484.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.6-0.9-0.8-3.6-7.7-4.6-4.7-5.9
Up moveDown movePending
AI summary

SBI Capital Markets filed an addendum dated July 17, 2026 to the open offer by Anupam Rasayan India Limited for up to 2,77,26,848 shares (26% of expanded voting capital) of Bliss GVS Pharma at ₹299 per share. Mates Visa Consultancy Private Limited, which became a wholly owned subsidiary of Anupam Rasayan effective July 17, 2026, has now been designated as Person Acting in Concert (PAC). Original public announcement was May 23, 2026; detailed public statement June 1, 2026; draft letter of offer June 8, 2026.

Likely market impact

Public shareholders should note Mates Visa added as PAC; offer price stays at ₹299 for 26% stake. Await final Letter of Offer for tendering details.